Use of peptide: HLA class II complexes to study specific T cells in myasthenia gravis

被引：0
|
作者：
Kishore, U [1 ]
Zhang, W [1 ]
Corlett, L [1 ]
Kelleher, A [1 ]
Shiono, H [1 ]
Willcox, N [1 ]
机构：
[1] John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DU, England
来源：
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY | 2002年 / 73卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：229 / 229
页数：1
相关论文
共 50 条
  • [21] Association of HLA Class II Alleles with Disease Severity and Treatment Response in Iranian Patients with Myasthenia Gravis
    Sinaei, Farnaz
    Fatehi, Farzad
    Gharan, Shahram Oveis
    Ehsan, Soroush
    Kamali, Koorosh
    Amirzargar, Aliakbar
    Mahmoudi, Mahdi
    Vaghefifar, Alaleh
    Nafissi, Shahriar
    JOURNAL OF NEUROMUSCULAR DISEASES, 2021, 8 (05) : 827 - 829
  • [22] THE USE OF THE POLYMERASE CHAIN-REACTION TO ANALYZE HLA CLASS-II SEQUENCE POLYMORPHISM AND GENETIC SUSCEPTIBILITY TO MYASTHENIA-GRAVIS
    BEGOVICH, AB
    OKSENBERG, JR
    GRIFFITH, RL
    STEINMAN, L
    ERLICH, HA
    HUMAN IMMUNOLOGY, 1988, 23 (02) : 81 - 81
  • [23] Use of ELISPOTS to monitor cloning of AChR-specific T-cells from myasthenia gravis patients
    Zhang, W
    Leite, I
    Kishore, U
    Water, P
    Willcox, N
    JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 150 - 150
  • [24] Biosynthetic and synthetic AChR sequences to study T cells in myasthenia gravis
    Diethelm-Okita, B
    Wells, G
    Kuryatov, A
    Okita, D
    Howard, J
    Lindstrom, J
    Conti-Fine, BM
    MYASTHENIA GRAVIS AND RELATED DISEASES: DISORDERS OF THE NEUROMUSCULAR JUNCTION, 1998, 841 : 320 - 323
  • [25] Rationale for a T cell receptor peptide therapy in myasthenia gravis
    Jambou, F
    Menestrier, M
    Klingel-Schmitt, I
    Caillat-Zucman, S
    Aïssaoui, A
    Berrih-Aknin, S
    Cohen-Kaminsky, S
    MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 : 320 - 323
  • [26] Binding of peptides of the human acetylcholine receptor alpha-subunit to HLA class II of patients with Myasthenia gravis
    Zisman, E
    Brautbar, C
    Sela, M
    Abramsky, O
    Battat, S
    Kirshner, SL
    KatzLevy, Y
    Dayan, M
    Mozes, E
    HUMAN IMMUNOLOGY, 1995, 44 (03) : 121 - 130
  • [27] Use of soluble MHC class II peptide multimers to detect antigen-specific T cells in human disease
    Bill, JR
    Kotzin, BL
    ARTHRITIS RESEARCH, 2002, 4 (04) : 261 - 265
  • [28] Use of soluble MHC class II/peptide multimers to detect antigen-specific T cells in human disease
    Jerome R Bill
    Brian L Kotzin
    Arthritis Research & Therapy, 4
  • [29] T-CELLS IN MYASTHENIA-GRAVIS SPECIFIC FOR EMBRYONIC ACETYLCHOLINE-RECEPTOR
    PROTTI, MP
    MANFREDI, AA
    HOWARD, JF
    CONTITRONCONI, BM
    NEUROLOGY, 1991, 41 (11) : 1809 - 1814
  • [30] Antigen specific B cells in myasthenia gravis patients
    Takata, Kazushiro
    Kinoshita, Makoto
    Mochizuki, Hideki
    Okuno, Tatsusada
    IMMUNOLOGICAL MEDICINE, 2020, 43 (02) : 65 - 71
12345